Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer
Shanna A. Arnold Egloff(Vanderbilt University Medical Center), Andries Zijlstra(Vanderbilt University)
Cited by 24
Related Papers
A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells
|Nature Communications|2020|311
Collagenolysis-dependent Angiogenesis Mediated by Matrix Metalloproteinase-13 (Collagenase-3)
|Journal of Biological Chemistry|2004|93
Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166
|Clinical & Experimental Metastasis|2019|42
Extracellular vesicle heterogeneity through the lens of multiomics
|Cell Reports Medicine|2025|33